✦ LIBER ✦

Parenteral nutrition–associated liver disease and the role for isolated intestine and intestine/liver transplantation

✍ Scribed by Alan L. Buchman; Kishore Iyer; Jonathan Fryer

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 471 KB
Volume: 43
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.20997

No coin nor oath required. For personal study only.

✦ Synopsis

Parenteral nutrition-associated liver disease (PNALD) is the most devastating complication of long-term parenteral nutrition therapy. Because its progression is typically insidious and its long-term consequences are generally underappreciated, PNALD is often recognized too late, when liver injury is irreversible. When end-stage liver disease (ESLD) develops in these patients, most potential interventions are futile and transplantation of both an intestine and a liver becomes the only viable option, despite the relatively poor outcomes associated with this combined procedure. Although likely multifactorial in origin, the etiology of PNALD is poorly understood. Early clinical intervention with a combination of nutritional, medical, hormonal, and surgical therapies can be effective in preventing liver disease progression. If these interventions fail, intestinal transplantation should be performed expeditiously before development of ESLD mandates simultaneous inclusion of a liver graft as well.

📜 SIMILAR VOLUMES

Liver transplantation for erythropoietic

Liver transplantation for erythropoietic protoporphyria in Europe

✍ Staffan Wahlin; Per Stal; Rene Adam; Vincent Karam; Robert Porte; Daniel Seehofe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

Liver transplantation is an established lifesaving treatment for patients with severe protoporphyric liver disease, but disease recurrence in the graft occurs for the majority of recipients. Severe burn injuries may occur when protective light filters are not used with surgical luminaires. Motor neu

Minimal criteria for placement of adults

Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases

✍ Lucey, M R ;Brown, K A ;Everson, G T ;Fung, J J ;Gish, R ;Keeffe, E B ;Kneteman, 📂 Article 📅 1997 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 103 KB 👁 1 views

This report summarizes a recent meeting cosponsored by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases to formulate minimal criteria by which patients with severe liver disease will be placed on the waiting list for liver transplantation. Th

Validation of the donor risk index in or

Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region

✍ Joris J. Blok; Andries E. Braat; Rene Adam; Andrew K. Burroughs; Hein Putter; Ni 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB 👁 1 views

In Eurotransplant, more than 50% of liver allografts come from extended criteria donors (ECDs). However, not every ECD is the same. The limits of their use are being explored. A continuous scoring system for analyzing donor risk has been developed within the Organ Procurement and Transplantation Net